LaunchPad Medical Inc.
his study constitutes the first clinical use of Tetranite®, a bone adhesive biomaterial. The purpose of the study is to show the safety and efficacy of Tetranite in immediately stabilizing dental implants following tooth extractions and its ability to obviate a costly, complex, and lengthy bone grafting procedure to accelerate the overall treatment timeframe for the many patients who suffer tooth loss.
FDA Grants ‘Breakthrough’ Designation to Eko’s ECG-based Low Ejection Fraction Screening Algorithm, Designed to Improve Detection of Heart Failure
The algorithm analyzes 15 seconds of ECG data collected from the Eko DUO digital stethoscope during a physical exam and helps identify reduced Left Ventricular Ejection Fraction (LVEF), a measure commonly used to diagnose patients with heart failure.
The RAPID artificial intelligence framework helps to quantify brain lesions and extend the window of potential stroke intervention from six hours after onset to up to 24 hours, for patients with salvageable brain tissue. RAPID provides physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke.
Etonogestrel/Ethinyl Estradiol Vaginal Ring is a small, flexible vaginal ring used by women to prevent pregnancy.
The company is developing an advanced platform of products based on silk protein - also known as fibroin - that has been shown to have unique properties for tissue support and regeneration.
The round was led by Northpond Ventures, a global firm dedicated to science and technology headquartered in Bethesda, Maryland.
PureTech Health Affiliate Gelesis Announces Partnership with Ro to Support US Commercialization of Plenity TM
In addition to collaborating with traditional healthcare providers, Gelesis will leverage Ro’s nationwide telehealth services to make Plenity available to patients who don’t have an established healthcare provider or prefer a remote interaction.
Aspen Surgical Inc.
Aspen Surgical reports the acquisition will advance leadership in orthopedic disposables.
The aggregate purchase price is €650,000 Euros (approximately $725,000), consisting of €350,000 cash and approximately 73,000 shares of common stock of Volition, for 100% of the outstanding shares of Octamer.
The 1.25 Micro Crown is designed with flexibility for tortuous vessels and tight bends below the knee.
The EXALT Model D Duodenoscope is the first and only FDA cleared single-use (disposable) duodenoscope on the market and was granted Breakthrough Device Designation from the FDA to ensure patients and healthcare providers have timely access to this device.
Expands testing and repair capabilities.
Primary Endpoint Achieved in Randomized, Controlled Trial of Digital Therapeutic AKL-T03 in Major Depressive Disorder
Results of the study were presented yesterday at the 58th Annual Meeting of the American College of Neuropsychopharmacology.
Ibex Medical Analytics
The system uses an artificial intelligence (AI) powered algorithm to analyse cases in parallel to pathologists and compares between the pathologists' diagnoses and the algorithm's findings, subsequently alerting in case of discrepancies with high clinical importance (e.g. a missed cancer).
Nihon Kohden Corporation
The monitor is designed for outpatient facilities and beds that traditionally are not continuously monitored.
Developed by physicians and neuroscientists at the University of Pittsburgh, Apollo’s gentle waves of vibration signal safety to the body through your sense of touch and rapidly improve heart rate variability, a key metric of health and recovery.
The successful first case was performed by Mark Archie, MD, principal investigator for the PROMISE II trial at Harbor-UCLA Medical Center, and Nina Bowens, MD, sub-investigator for the PROMISE II trial at Harbor-UCLA Medical Center.
Mr. D'Agostino is the retired founder and Executive Director of the LSU Innovation Park and the Louisiana Business & Technology Center ("LBTC") at Louisiana State University and has been actively involved in entrepreneurship, economic development, and technology transfer for the last 30 years